← Snapshot 21

Orange Book snapshot 21: Products

Products page 285 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
14202N050523001VIDARABINEINJECTABLE;INJECTIONINJECTABLEINJECTIONVIRA-APARKEDALEEQ 187.4MG BASE/ML[]Approved Prior to Jan 1, 1982YesNoNoDISCNPARKEDALE PHARMACEUTICALS INCddee3fef75ffc6cd29a209dc7e3e35aa668faa03957dcf372b978a639258896c
14203N020351001IODIXANOLINJECTABLE;INJECTIONINJECTABLEINJECTIONVISIPAQUE 270GE HEALTHCARE55%[]1996-03-22Mar 22, 1996NoYesYesRXGE HEALTHCAREcfcbac4853eef1dffcb484745a87f731e1fd735a86e4bda59f77273979836d51
14204N020808001IODIXANOLINJECTABLE;INJECTIONINJECTABLEINJECTIONVISIPAQUE 270GE HEALTHCARE55%[]1997-08-29Aug 29, 1997NoNoNoDISCNGE HEALTHCAREa09a1b828a5b744dbf298ab0617eedbcfec6596923c4fcff95c1beda76ad2956
14205N020351002IODIXANOLINJECTABLE;INJECTIONINJECTABLEINJECTIONVISIPAQUE 320GE HEALTHCARE65.2%[]1996-03-22Mar 22, 1996NoYesYesRXGE HEALTHCAREfb1d2f2e3987df977cbfca5875329bee7485aab3e4513a38ba882e7778e8fb49
14206N020808002IODIXANOLINJECTABLE;INJECTIONINJECTABLEINJECTIONVISIPAQUE 320GE HEALTHCARE65.2%[]1997-08-29Aug 29, 1997NoNoNoRXGE HEALTHCARE96757167ffa4062c841705243f2bedadc6b3eb1a544484af10e7d4390e21a5c3
14207N011111001HYDROXYZINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONVISTARILPFIZER25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNPFIZER LABORATORIES DIV PFIZER INC1d805326e55b0bbe2a8826f4cc780355ad4a715130450090d6b6b3f54a62ef36
14208N011111002HYDROXYZINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONVISTARILPFIZER50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNPFIZER LABORATORIES DIV PFIZER INC5ccb975fa697ceca7a293432fc0e710a356c18b6693c239cb777ce9b320a9120
14209N020638001CIDOFOVIRINJECTABLE;INJECTIONINJECTABLEINJECTIONVISTIDEGILEAD SCIENCES INCEQ 75MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1996-06-26Jun 26, 1996NoYesNoDISCNGILEAD SCIENCES INCb9cf8c973caa2cc59d98a30e6a325495d5be3792606d14ebf9e92be1654b902d
14210N021119001VERTEPORFININJECTABLE;INJECTIONINJECTABLEINJECTIONVISUDYNEVALEANT LUXEMBOURG15MG/VIAL[]2000-04-12Apr 12, 2000NoYesYesRXVALEANT PHARMACEUTICALS LUXEMBOURG SARL74b899407bc9041647edf97e4d61a0db3297b9bca6bd31266964d731fa43e450
14211A080819001VITAMIN A PALMITATEINJECTABLE;INJECTIONINJECTABLEINJECTIONVITAMIN A PALMITATEBEL MAREQ 50,000 UNITS BASE/ML[]Approved Prior to Jan 1, 1982YesNoNoDISCNBEL MAR LABORATORIES INCe4a834b4ff25f8b8d6119c0354260a35abf9592940f48b52431476c9990f3ba2
14212A087954001PHYTONADIONEINJECTABLE;INJECTIONINJECTABLEINJECTIONVITAMIN K1HOSPIRA1MG/0.5MLBP["BP"]1983-07-25Jul 25, 1983NoNoYesRXHOSPIRA INCbf12849ff5a678fdbe7fbddbe9b4f13f6421404147b46982b5690e82dca1d857
14213A087955001PHYTONADIONEINJECTABLE;INJECTIONINJECTABLEINJECTIONVITAMIN K1HOSPIRA10MG/MLAB["AB"]1983-07-25Jul 25, 1983NoNoYesRXHOSPIRA INC46e388198d6fc82a4b279405b8358da8ca161a5ec4b3cb8b9d48672ee5d2e04d
14214A087956001PHYTONADIONEINJECTABLE;INJECTIONINJECTABLEINJECTIONVITAMIN K1HOSPIRA10MG/ML[]1983-07-25Jul 25, 1983NoNoNoDISCNHOSPIRA INC2d37f66176dfd953d5e51579d9c5e754fe4ffb9f402c88dfde2cc6c0d6e03f7b
14215N020176001ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN EINJECTABLE;INJECTIONINJECTABLEINJECTIONVITAPEDHOSPIRAN/A,80MG/VIAL;N/A,0.02MG/VIAL;N/A,0.001MG/VIAL;400 IU/10ML,N/A;N/A,0.14MG/VIAL;N/A,17MG/VIAL;N/A,5MG/VIAL;0.2MG/10ML,N/A;N/A,1MG/VIAL;N/A,1.4MG/VIAL;N/A,1.2MG/VIAL;EQ 2,300 UNITS BASE/10ML,N/A;7 IU/10ML,N/A[]1993-12-29Dec 29, 1993NoNoNoDISCNHOSPIRA INC9d2e9e74209533984962af8d140ff13eb340c272c5f657f0977f39fb0abc2466
14216N020961001FOMIVIRSEN SODIUMINJECTABLE;INJECTIONINJECTABLEINJECTIONVITRAVENE PRESERVATIVE FREENOVARTIS6.6MG/ML[]1998-08-26Aug 26, 1998NoNoNoDISCNNOVARTIS PHARMACEUTICALS CORP9119421fe3c95ec7f8eff8f4c98219dad01d8ef94627ea45de8054a3256327fd
14217N020119001TENIPOSIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONVUMONHQ SPECLT PHARMA10MG/ML[]1992-07-14Jul 14, 1992NoYesNoDISCNHQ SPECIALTY PHARMA169e47253718d8641e8cff4527e1f43dd47789b47a471e080b814a2ce6816f4c
14218A087439001LEUCOVORIN CALCIUMINJECTABLE;INJECTIONINJECTABLEINJECTIONWELLCOVORINGLAXOSMITHKLINEEQ 5MG BASE/ML[]1982-10-19Oct 19, 1982NoNoNoDISCNGLAXOSMITHKLINE53e915334b01608e25f0eb0040f6c033beff5bdada46c56b33fc7021dc6780fe
14219A089833001LEUCOVORIN CALCIUMINJECTABLE;INJECTIONINJECTABLEINJECTIONWELLCOVORINGLAXOSMITHKLINEEQ 25MG BASE/VIAL[]1989-01-23Jan 23, 1989NoNoNoDISCNGLAXOSMITHKLINE703eee74c897665946b4678fd327af7ef30c762671cb63943290ba6dc74accb2
14220A089465001LEUCOVORIN CALCIUMINJECTABLE;INJECTIONINJECTABLEINJECTIONWELLCOVORINGLAXOSMITHKLINEEQ 50MG BASE/VIAL[]1989-01-23Jan 23, 1989NoNoNoDISCNGLAXOSMITHKLINEd81402aedbdb90cd91437d1ac9d1da4a0f67309376967229191177c4b3c5aab7
14221A089834001LEUCOVORIN CALCIUMINJECTABLE;INJECTIONINJECTABLEINJECTIONWELLCOVORINGLAXOSMITHKLINEEQ 100MG BASE/VIAL[]1989-01-23Jan 23, 1989NoNoNoDISCNGLAXOSMITHKLINEac98aba7f1d14604a6a1fd8316735e72d3a7f1c022d3167b061c7e5aa1ad898d
14222N008248002MEPHENTERMINE SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONWYAMINE SULFATEBAXTER HLTHCARE CORPEQ 15MG BASE/ML[]Approved Prior to Jan 1, 1982YesNoNoDISCNBAXTER HEALTHCARE CORP ANESTHESIA CRITICAL CAREd95d0d75d305024f39824aaf8ce6b7160d96984569d3fd812e13553111770325
14223N008248001MEPHENTERMINE SULFATEINJECTABLE;INJECTIONINJECTABLEINJECTIONWYAMINE SULFATEBAXTER HLTHCARE CORPEQ 30MG BASE/ML[]Approved Prior to Jan 1, 1982YesNoNoDISCNBAXTER HEALTHCARE CORP ANESTHESIA CRITICAL CARE82990e84489d49be1eab421451aea4b22d5018f2137806f12b849130f8bcbdb6
14224N017256001XENON XE-133INJECTABLE;INJECTIONINJECTABLEINJECTIONXENON XE 133GE HEALTHCARE1.3-1.7 CI/AMP[]Approved Prior to Jan 1, 1982YesNoNoDISCNGE HEALTHCARE3b3e9092baf250f50e39101b133f3c9a2a804def1056cbcb894e08bc36797817
14225N017283001XENON XE-133INJECTABLE;INJECTIONINJECTABLEINJECTIONXENON XE 133LANTHEUS MEDCL6.3mCi/ML[]Approved Prior to Jan 1, 1982YesNoNoDISCNLANTHEUS MEDICAL IMAGING INCe5413f974f02a70a72e98032ecfd3ad2176c6a057a1207f853d4fbc0e2874219
14226N010418005LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINEASTRAZENECA1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTRAZENECA LPa19714ba152970fa1da74f64bfd4b253d9e77bab566e2fb3529ed7a75ae1868e
14227N010418009LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINEASTRAZENECA1.5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTRAZENECA LPe7aec9993b33c2bd1aa8dd6f2376ee181383f4cbdc6a566ef4238ae9c3199bb1
14228N010418007LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINEASTRAZENECA2%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTRAZENECA LP285bb64f2540ebec7e1caf9ad50707c37bedc02485b041946b6e8d36f6eb4cae
14229N006488008LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINEFRESENIUS KABI USA0.5%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLC53c865f867ffff0bb16531e489d1f4ff48ccb431a1978aff76feab7b0159aaa0
14230N006488007LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINEFRESENIUS KABI USA1%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLCa69033ec13102137c473f72dcbc1a98f6fd06a1c36be0c14a77e990958d1cb63
14231N006488010LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINEFRESENIUS KABI USA1.5%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLC23fa4ac9c931db011ae4409ffde5afc544b9d7553518e94624b72585089b7245
14232N006488002LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINEFRESENIUS KABI USA2%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLCd3dcd15e00632c46cb8805ea6dde60d7bcef766c122e1a412b73935ecb127bd6
14233N010417001LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE 4% PRESERVATIVE FREEFRESENIUS KABI USA4%[]Approved Prior to Jan 1, 1982YesYesNoDISCNFRESENIUS KABI USA LLC862186e319cb135c6e1f7396bcb3239d24a5b0fe90816a40ef2a26aea23184fc
14234N021380001LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE DENTALDENTSPLY PHARM2%[]Approved Prior to Jan 1, 1982YesNoNoDISCNDENTSPLY PHARMACEUTICAL INCe4d17af4e6a60835447251de56423a310ec5a3d784b9dde314951dfbdf2d9505
14235N021381001EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE DENTAL WITH EPINEPHRINEDENTSPLY PHARM0.01MG/ML;2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNDENTSPLY PHARMACEUTICAL INC4d8d88681e4f6fe17d03a60fb8b5ae9d3d82f525ca83467b1b572b997c227406
14236N021381002EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE DENTAL WITH EPINEPHRINEDENTSPLY PHARM0.02MG/ML;2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNDENTSPLY PHARMACEUTICAL INC5509dff82b91d33af24cda766ad11791d91e93114698506ae4290ef7aeec081b
14237N016801005LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE PRESERVATIVE FREEFRESENIUS KABI USA1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1988-01-19Jan 19, 1988NoYesNoDISCNFRESENIUS KABI USA LLCdbe5ba39bc501a8a9c815f8f4b23c3891a91624aa376662e684c1286036fc79b
14238N016801001LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE PRESERVATIVE FREEFRESENIUS KABI USA2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNFRESENIUS KABI USA LLC80ce23a2ba1f793ccaf23a08bdea2951bad52210e50761d3549cc4b3fc16fdaa
14239N016801002LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE PRESERVATIVE FREEFRESENIUS KABI USA4% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNFRESENIUS KABI USA LLC71e7208749a842a651eb74a26b95caac8de90c4ba88574f7c669da5b925f9c23
14240N016801003LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE PRESERVATIVE FREEFRESENIUS KABI USA10% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNFRESENIUS KABI USA LLC532c2b96c7d0ebd20c4d2e7c526fefb093cccb633ac4e00f76d29c666ab23cef
14241N016801004LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE PRESERVATIVE FREEFRESENIUS KABI USA20% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesYesNoDISCNFRESENIUS KABI USA LLC259094a07e227c7bb3aba2210da95a173d90dd9c67c2478a76977060898fb7d2
14242N010418006EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEASTRAZENECA0.005MG/ML;1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTRAZENECA LPcce56eb0ac80a094e6f45095e28e37a0bf5c85cdc974bcd114c4a03ccc326847
14243N010418010EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEASTRAZENECA0.005MG/ML;1.5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTRAZENECA LPbc7e31f88af89523212961d872d3ea412d05a45c6965539e32cd140a1f1b8467
14244N010418008EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEASTRAZENECA0.005MG/ML;2%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTRAZENECA LP91d82c4f897464226826056df2653318c4308d7c5edc64814eb4820dc3dc8d2b
14245N006488012EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEFRESENIUS KABI USA0.005MG/ML;0.5%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLC08b9ff4c6b14569f363fb8a41c773c37aa53e311c6b41e267b91834ca28479b7
14246N006488018EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEFRESENIUS KABI USA0.005MG/ML;1%[]1986-11-13Nov 13, 1986NoYesYesRXFRESENIUS KABI USA LLC31bae1d7a6e0788e8caa1ee6d16d3c0835fff3f57145eab737c2d82a17b2cbcb
14247N006488017EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEFRESENIUS KABI USA0.005MG/ML;1.5%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLC842e741187962f3c8d697d607dc94be27ab455770116ce61d44b237938de6d4e
14248N006488019EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEFRESENIUS KABI USA0.005MG/ML;2%AP["AP"]1986-11-13Nov 13, 1986NoYesYesRXFRESENIUS KABI USA LLC453ebb9cc4f2079298cc12160f01ffdf73f9314aefe1077edccb369f0638eaf0
14249N006488004EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEFRESENIUS KABI USA0.01MG/ML;1%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLC355981b7e786c7d6a589b98862d33f79b1008e91148648a25705089ee9166332
14250N006488003EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEFRESENIUS KABI USA0.01MG/ML;2%[]Approved Prior to Jan 1, 1982YesNoNoDISCNFRESENIUS KABI USA LLC36558a2c7e1b0857fedc25d6d387108466a4c0c7b636fb4a2c74b6e4e6bdd6ca
14251N006488005EPINEPHRINE; LIDOCAINE HYDROCHLORIDEINJECTABLE;INJECTIONINJECTABLEINJECTIONXYLOCAINE W/ EPINEPHRINEFRESENIUS KABI USA0.02MG/ML;2%AP["AP"]Approved Prior to Jan 1, 1982YesYesYesRXFRESENIUS KABI USA LLC254b2dcea30737e2a5a0e85ecf30c4bbc6b9615d003695d8cfcbd52d7aad0710